article thumbnail

Pfizer Buys Seagen In $43B Enterprise Value Deal

Law 360 M&A

Pfizer said Monday it has entered into an agreement to acquire global cancer biotechnology company Seagen for $229 in cash per Seagen share, giving the transaction a total enterprise value of $43 billion.

article thumbnail

Biogen Bolsters Rare Disease Portfolio, Agrees To Buy Reata Pharmaceuticals With Enterprise Value Of $7.3B

Benzinga

per share in cash, reflecting an enterprise value of approximately $7.3 Biogen Inc (NASDAQ: BIIB ) has agreed to acquire Reata Pharmaceuticals Inc (NASDAQ: RETA ) for $172.50 Reata's FDA-approved Skyclarys (omaveloxolone) is the first and only approved treatment for Friedreich's ataxia (FA) in the U.S.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Latham Leads Boston Scientific On $1.16B Silk Road Deal

Law 360 M&A

represented by Wilson Sonsini, at an enterprise value of approximately $1.16 Latham & Watkins-advised Boston Scientific Corp. said Tuesday it has agreed to acquire medical device maker Silk Road Medical Inc.,

article thumbnail

Regency Centers Closes Urstadt Biddle Properties Buyout, Combined Enterprise Value At $16B

Benzinga

Regency Centers Corp (NASDAQ: REG ) disclosed the completion of the acquisition of Urstadt Biddle Properties Inc. In May, the company announced an all-stock transaction for around $1.4 The combined company will have a pro forma equity market capitalization of. Full story available on Benzinga.com

article thumbnail

3 Firms Rep As Waste Management Inks $7.2B Stericycle Buy

Law 360 M&A

has agreed to buy medical waste company Stericycle at an enterprise value of about $7.2 Waste Management Inc. billion, inclusive of approximately $1.4 billion of debt, the companies said in a statement Monday.

article thumbnail

Absolute Software to be Acquired by Crosspoint Capital Partners for Enterprise Value of US$870 Million

Business Wire M&A

VANCOUVER, British Columbia & SAN JOSE, Calif.--(BUSINESS BUSINESS WIRE)--Absolute Software™ (“Absolute” or the “Company”) (NASDAQ: ABST) (TSX: ABST), the only provider of self-healing, intelligent security solutions, today announced it has entered into an Arrangement Agreement with funds affiliated with Crosspoint Capital Partners, L.P.

article thumbnail

Perspectives Paper: Human Capital

IVSC

Evidence suggests that investors require more information on the impact Human Capital has on enterprise value. Recognising the importance of Human Capital is obvious but understanding and measuring its role in enterprise value creation is much more difficult. Download the paper.